Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L02BG06	EXEMESTANE BGR	G	Exemestane - 25mg	25mg	Tablet, coated	4,479,027 L.L
D08AX02	EOSIN ALCOHOLIC	G	Eosin - 2%	2%	Solution	115,187 L.L
L02BG06	EXEMESTANE GENEPHARM	G	Exemestane - 25mg	25mg	Tablet, film coated	1,286,662 L.L
D08AX02	EOSIN AQUEUSE	G	Eosin - 2%	2%	Solution	98,548 L.L
L02BG06	EXEMESTANE GP PHARM	G	Exemestane - 25mg	25mg	Tablet, film coated	1,158,392 L.L
D08AX02	EOSIN ALCOHOLIC	G	Eosin - 1%	1%	Solution	108,787 L.L
D08AX02	EOSIN AQUEUSE	G	Eosin - 1%	1%	Solution	84,470 L.L
J01MA02	ESTECINA 500MG	G	Ciprofloxacine (HCl) - 500mg	500mg	Tablet, film coated	618,168 L.L
G04BE08	ENKOR	G	Tadalafil - 5mg	5mg	Tablet, film coated	1,766,193 L.L
J01MA02	ESTECINA 200MG	G	Ciprofloxacine (lactate) - 200mg/100ml	200mg/100ml	Injectable solution	32,190,251 L.L
A08AB01	ELIZA 120	G	Orlistat - 120mg	120mg	Capsule	1,167,223 L.L
A08AB01	ELIZASLIM 120	G	Orlistat - 120mg	120mg	Capsule	1,167,223 L.L
D10AD51	ERYLIK	G	Tretinoin - 0.025%, Erythromycin - 4%		Gel	378,964 L.L
L01EG02	EVEROLIMUS ARROW	G	Everolimus - 2.5mg	2.5mg	Tablet	L.L
B03AB	ENRICH N	G	Iron trivalent (hydroxide polymaltose complex) - 156.25mg/5ml		Syrup	279,519 L.L
J01MA12	EVOXIL HELLAS	G	Levofloxacin - 500mg/100ml	500mg/100ml	Injectable solution	959,504 L.L
L01EG02	EVEROLIMUS ARROW	G	Everolimus - 5mg	5mg	Tablet	L.L
B03AB05	ENRICH N	G	Iron trivalent (hydroxide polymaltose complex) - 50mg/ml	50mg/ml	Drops	459,594 L.L
L01EG02	EVEROLIMUS ARROW	G	Everolimus - 10mg	10mg	Tablet	L.L
A11CC05	EURO D 10000 IU	G	Vitamin D3 - 10,000IU	10,000IU	Capsule	993,100 L.L
L01EG02	EVEROLIMUS ARROW	G	Everolimus - 5mg	5mg	Tablet	73,160,279 L.L
L01EG02	EVEROLIMUS BIOGARAN	G	Everolimus - 5mg	5mg	Tablet	89,386,347 L.L
J05AF10	ENTECAVIR ARROW	G	Entecavir - 1mg	1mg	Tablet, coated	L.L
J05AF10	ENTECAVIR ARROW	G	Entecavir - 0.5mg	0.5mg	Tablet, coated	L.L
L01EG02	EVEROLIMUS ARROW	G	Everolimus - 10mg	10mg	Tablet	91,752,764 L.L
L01EG02	EVEROLIMUS BIOGARAN	G	Everolimus - 10mg	10mg	Tablet	124,701,632 L.L
B03AD	EURO-FER CF	G	Folic acid - 0.5mg, Vitamin C - 200mg, Ferrous fumarate - 300mg		Capsule	706,861 L.L
L01EG02	EVEROLIMUS ARROW	G	Everolimus - 2.5mg	2.5mg	Tablet	57,802,039 L.L
A02BC05	ESO TAD	G	Esomeprazole - 20mg	20mg	Capsule, hard, gastro-resistant	299,677 L.L
D10AF02	ERYTHROMYCIN 1.5 %	G	Erythromycin - 15mg/ml	1.5 %	Solution	501,701 L.L

...